Evaluation of five different methods for diagnosis of Helicobacter pylori from fecal samples
APMIS · 2025
DOI: 10.1111/apm.13483 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift APMIS, 2025. Verfasst von Jenni Horsma-Heikkinen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Feces, Helicobacter pylori, Helicobacter Infections, Sensitivity and Specificity. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: HUS Diagnostic Center.
Abstract (Originalsprache)
Accurate detection of Helicobacter pylori and its antimicrobial resistance is essential for eradication of the infections. The aim of this study was to compare five different CE‐IVD marked assays in detection of H. pylori from 268 clinical stool samples. Samples were considered positive for H. pylori when at least three of the five tests were positive. Amplified IDEIA Hp StAR (Oxoid) and Premier Platinum HpSA PLUS (Meridian Bioscience Inc.) assays showed sensitivity of 100% [95% CI (confidence interval): 87–100] and LIAISON® Meridian H. pylori SA (DiaSorin) of 83.3% (95% CI: 66–93). Specificities of the assays were 94.5% (95% CI: 91–97), 95.4%; (95% CI: 92–97), and 97.1% (95% CI: 94–99) respectively. Amplidiag® H. pylori + ClariR (Mobidiag) assay showed 93.3% (95% CI: 78–99) and Allplex™ H. pylori & ClariR Assay (Seegene Inc.) 36.7% (95% CI: 22–55) sensitivity, while specificity of both was 97.9% (95% CI: 95–99). The Amplidiag® and Allplex™ assays concordantly detected clarithromycin resistance in positive for H. pylori samples. The Amplidiag® assay showed the highest accuracy, namely 97.4% (95% CI: 95–99). These data provide helpful information for planning laboratory diagnostics of H. pylori and detection of clarithromycin resistance from stool samples.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Microbiology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
ORCID-Profile: Jenni Horsma-Heikkinen
Förderung
- HUS Diagnostic Center
Zitieren
APA
Horsma-Heikkinen, J., Pätäri-Sampo, A., Holma, T., Nevalainen, A., Friberg, N., Jarva, H., Loginov, R., & Antikainen, J. (2025). Evaluation of five different methods for diagnosis of Helicobacter pylori from fecal samples. APMIS. https://doi.org/10.1111/apm.13483
Vancouver
Horsma-Heikkinen J, Pätäri-Sampo A, Holma T, Nevalainen A, Friberg N, Jarva H, et al. Evaluation of five different methods for diagnosis of Helicobacter pylori from fecal samples. APMIS. 2025. doi:10.1111/apm.13483
BibTeX
@article{HorsmaHeikkinen2025,
author = {Horsma-Heikkinen, Jenni and Pätäri-Sampo, Anu and Holma, Tanja and Nevalainen, Annika and Friberg, Nathalie and Jarva, Hanna and Loginov, Raisa and Antikainen, Jenni},
title = {Evaluation of five different methods for diagnosis of Helicobacter pylori from fecal samples},
journal = {APMIS},
year = {2025},
doi = {10.1111/apm.13483}
}
EUVIMED